The Expression of the Beta Cell-Derived Autoimmune Ligand for the Killer Receptor Nkp46 Is Attenuated in Type 2 Diabetes

• Chamutal Gur ,

  Contributed equally to this work with: Chamutal Gur, Jonatan Enk, Gill Leibowitz, Ofer Mandelboim

  Affiliations The Lautenberg Center for General and Tumor Immunology, The Department of Immunology and Cancer Research, The Institute for Medical Research Israel Canada; and The Hebrew University-Hadassah Medical School, Jerusalem, Israel, Department of Internal Medicine, Hadassah-Hebrew University Medical Center, Jerusalem Israel

  ⨯
• Jonatan Enk ,

  Contributed equally to this work with: Chamutal Gur, Jonatan Enk, Gill Leibowitz, Ofer Mandelboim

  Affiliation The Lautenberg Center for General and Tumor Immunology, The Department of Immunology and Cancer Research, The Institute for Medical Research Israel Canada; and The Hebrew University-Hadassah Medical School, Jerusalem, Israel

  ⨯
• Efraim Weitman,

  Affiliation Department of Pathology and the Lautenberg Center for Immunology, Institute for Medical Research Israel-Canada, Hebrew University Hadassah Medical School, Jerusalem, Israel

  ⨯
• Etty Bachar,

  Affiliation Endocrinology and Metabolism Service, Department of Internal Medicine, Hadassah-Hebrew University Medical Center, Jerusalem, Israel

  ⨯
• Yaron Suissa,

  Affiliation Department of Developmental Biology and Cancer Research, The institute for Medical Research Israel-Canada, The Hebrew University-Hadassah Medical School, Jerusalem, Israel

  ⨯
• Guy Cohen,

  Affiliation Institute for Drug Research-Department of Pharmacology, The Hebrew University of Jerusalem, Jerusalem, Israel

  ⨯
• Rachel Ben-Haroush Schyr,

  Affiliation Endocrinology and Metabolism Service, Department of Internal Medicine, Hadassah-Hebrew University Medical Center, Jerusalem, Israel

  ⨯
• Helena Sabanay,

  Affiliation Electron Microscopy Center, The Weizmann Institute of Science, Rehovot, Israel

  ⨯
• Elad Horwitz,

  Affiliation The Lautenberg Center for General and Tumor Immunology, The Department of Immunology and Cancer Research, The Institute for Medical Research Israel Canada; and The Hebrew University-Hadassah Medical School, Jerusalem, Israel

  ⨯
• Benjamin Glaser,

  Affiliation Endocrinology and Metabolism Service, Department of Internal Medicine, Hadassah-Hebrew University Medical Center, Jerusalem, Israel

  ⨯
• Yuval Dor,

  Affiliation Department of Developmental Biology and Cancer Research, The institute for Medical Research Israel-Canada, The Hebrew University-Hadassah Medical School, Jerusalem, Israel

  ⨯
• Ariel Pribluda,

  Affiliation Department of Molecular Genetics, The Weizmann Institute of Science, Rehovot, Israel

  ⨯
• Jacob H. Hanna,

  Affiliation Department of Molecular Genetics, The Weizmann Institute of Science, Rehovot, Israel

  ⨯
• Gill Leibowitz ,

  Contributed equally to this work with: Chamutal Gur, Jonatan Enk, Gill Leibowitz, Ofer Mandelboim

  Affiliation Endocrinology and Metabolism Service, Department of Internal Medicine, Hadassah-Hebrew University Medical Center, Jerusalem, Israel

  ⨯
• Ofer Mandelboim

  Contributed equally to this work with: Chamutal Gur, Jonatan Enk, Gill Leibowitz, Ofer Mandelboim

  * E-mail: oferm@ekmd.huji.ac.il (GL)

  Affiliation The Lautenberg Center for General and Tumor Immunology, The Department of Immunology and Cancer Research, The Institute for Medical Research Israel Canada; and The Hebrew University-Hadassah Medical School, Jerusalem, Israel

  ⨯